miR-150 for the treatment of blood disorders
US8530443B2 · kind B2 · utility
0Cited by
1References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 16, 2012 |
| Grant date | Sep 10, 2013 |
| Priority date | — |
| Expiry date | Oct 16, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2330/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods of treating certain blood related disorders, in particular, thrombocytopenia and anemia comprising increasing miR-150 expression or inhibiting miR-150 in progenitor cells respectively.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.